Annual report pursuant to Section 13 and 15(d)

Balance Sheet Components - Components of Accrued Liabilities (Detail)

v3.23.1
Balance Sheet Components - Components of Accrued Liabilities (Detail) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Accrued liabilities:    
General and administrative $ 855 $ 794
Clinical trial related costs 1,327 1,134
Non-clinical research and manufacturing operations 1,779 2,153
Payroll related 4,828 5,388
Other accrued expenses 34 46
Total Accrued liabilities $ 8,823 $ 9,515